Literature DB >> 20068595

Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis.

Kathryn E McDougal1, Deanna M Green, Lori L Vanscoy, M Daniele Fallin, Michael Grow, Suzanne Cheng, Scott M Blackman, J Michael Collaco, Lindsay B Henderson, Kathleen Naughton, Garry R Cutting.   

Abstract

Variants in mannose-binding lectin (MBL2; protein MBL) have shown association with different aspects (eg, lung function, infection, survival) of cystic fibrosis (CF) in some studies but not others. Inconsistent results may be due to confounding among disease variables that were not fully accounted for in each study. To account for these relationships, we derived a modeling framework incorporating CFTR genotype, age, Pseudomonas aeruginosa (Pa) infection, and lung function from 788 patients in the US CF Twin and Sibling Study. This framework was then used to identify confounding variables when testing the effect of MBL2 variation on specific CF traits. MBL2 genotypes corresponding to low levels of MBL associated with Pa infection 1.94 years earlier than did MBL2 genotypes corresponding to high levels of MBL (P=0.0034). In addition, Pa-infected patients with MBL2 genotypes corresponding to low levels of MBL underwent conversion to mucoid Pa 2.72 years earlier than did patients with genotypes corresponding to high levels of MBL (P=0.0003). MBL2 was not associated with the time to transition from infection to conversion or with lung function. Thus, use of a modeling framework that identified confounding among disease variables revealed that variation in MBL2 associates with age at infection with Pa and age at conversion to mucoid Pa in CF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20068595      PMCID: PMC2874654          DOI: 10.1038/ejhg.2009.226

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

1.  Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study.

Authors:  M Gabolde; M Guilloud-Bataille; J Feingold; C Besmond
Journal:  BMJ       Date:  1999-10-30

2.  Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; Martha M Werler; Allen A Mitchell
Journal:  Am J Epidemiol       Date:  2002-01-15       Impact factor: 4.897

3.  Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes.

Authors:  N Baxter; M Sumiya; S Cheng; H Erlich; L Regan; A Simons; J A Summerfield
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 4.  Problems of reporting genetic associations with complex outcomes.

Authors:  Helen M Colhoun; Paul M McKeigue; George Davey Smith
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

5.  Polymorphisms in the mannose binding lectin gene affect the cystic fibrosis pulmonary phenotype.

Authors:  J Yarden; D Radojkovic; K De Boeck; M Macek; D Zemkova; V Vavrova; R Vlietinck; J-J Cassiman; H Cuppens
Journal:  J Med Genet       Date:  2004-08       Impact factor: 6.318

6.  Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition.

Authors:  M R Kosorok; L Zeng; S E West; M J Rock; M L Splaingard; A Laxova; C G Green; J Collins; P M Farrell
Journal:  Pediatr Pulmonol       Date:  2001-10

7.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood
Journal:  J Pediatr       Date:  2001-05       Impact factor: 4.406

8.  Mannose-binding lectin variant alleles and the risk of arterial thrombosis in systemic lupus erythematosus.

Authors:  Tommy Øhlenschlaeger; Peter Garred; Hans O Madsen; Søren Jacobsen
Journal:  N Engl J Med       Date:  2004-07-15       Impact factor: 91.245

9.  Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.

Authors:  Lindsay A Bremer; Scott M Blackman; Lori L Vanscoy; Kathryn E McDougal; Amanda Bowers; Kathleen M Naughton; David J Cutler; Garry R Cutting
Journal:  Hum Mol Genet       Date:  2008-04-17       Impact factor: 6.150

10.  Development and evaluation of a PCR-based, line probe assay for the detection of 58 alleles in the cystic fibrosis transmembrane conductance regulator (CFTR) gene.

Authors:  XinJing Wang; Angela Myers; Randall K Saiki; Garry R Cutting
Journal:  Clin Chem       Date:  2002-07       Impact factor: 8.327

View more
  9 in total

1.  Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Deanna M Green; J Michael Collaco; Kathryn E McDougal; Kathleen M Naughton; Scott M Blackman; Garry R Cutting
Journal:  J Pediatr       Date:  2012-02-23       Impact factor: 4.406

2.  The influence of genetics on cystic fibrosis phenotypes.

Authors:  Michael R Knowles; Mitchell Drumm
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 3.  Modifier genes in Mendelian disorders: the example of cystic fibrosis.

Authors:  Garry R Cutting
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

Review 4.  Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.

Authors:  Jason P Eiserich; Jun Yang; Brian M Morrissey; Bruce D Hammock; Carroll E Cross
Journal:  Ann N Y Acad Sci       Date:  2012-07       Impact factor: 5.691

5.  Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.

Authors:  Jun Yang; Jason P Eiserich; Carroll E Cross; Brian M Morrissey; Bruce D Hammock
Journal:  Free Radic Biol Med       Date:  2012-05-08       Impact factor: 7.376

6.  PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients.

Authors:  M Chiarini; C Sabelli; P Melotti; C Garlanda; G Savoldi; C Mazza; R Padoan; A Plebani; A Mantovani; L D Notarangelo; B M Assael; R Badolato
Journal:  Genes Immun       Date:  2010-10-07       Impact factor: 2.676

7.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

Review 8.  Disease-modifying genes and monogenic disorders: experience in cystic fibrosis.

Authors:  Sabina Gallati
Journal:  Appl Clin Genet       Date:  2014-07-10

9.  Applying whole-genome sequencing in relation to phenotype and outcomes in siblings with cystic fibrosis.

Authors:  Melissa A Wilk; Andrew T Braun; Philip M Farrell; Anita Laxova; Donna M Brown; James M Holt; Camille L Birch; Nadiya Sosonkina; Brandon M Wilk; Elizabeth A Worthey
Journal:  Cold Spring Harb Mol Case Stud       Date:  2020-02-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.